AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.98 $1.40 Thursday, 23rd May 2024 LCTX stock ended at $1.03. This is 1.90% less than the trading day before Wednesday, 22nd May 2024. During the day the stock fluctuated 4.95% from a day low at $1.01 to a day high of $1.06.
90 days $0.98 $1.61
52 weeks $0.84 $1.61

Historical Lineage Cell Therapeutics, Inc. prices

Date Open High Low Close Volume
Jun 07, 2018 $2.43 $2.44 $2.30 $2.30 293 266
Jun 06, 2018 $2.51 $2.52 $2.38 $2.40 309 435
Jun 05, 2018 $2.41 $2.53 $2.41 $2.49 462 498
Jun 04, 2018 $2.44 $2.52 $2.35 $2.37 685 178
Jun 01, 2018 $2.25 $2.38 $2.24 $2.38 400 357
May 31, 2018 $2.24 $2.27 $2.23 $2.24 262 979
May 30, 2018 $2.20 $2.25 $2.20 $2.22 189 911
May 29, 2018 $2.20 $2.24 $2.13 $2.19 285 483
May 25, 2018 $2.22 $2.25 $2.16 $2.20 245 696
May 24, 2018 $2.28 $2.28 $2.20 $2.21 206 020
May 23, 2018 $2.27 $2.32 $2.24 $2.25 193 294
May 22, 2018 $2.33 $2.34 $2.28 $2.30 205 101
May 21, 2018 $2.37 $2.42 $2.27 $2.30 239 370
May 18, 2018 $2.35 $2.44 $2.22 $2.37 505 181
May 17, 2018 $2.24 $2.27 $2.20 $2.25 326 324
May 16, 2018 $2.23 $2.28 $2.22 $2.24 278 535
May 15, 2018 $2.20 $2.28 $2.16 $2.23 504 922
May 14, 2018 $2.20 $2.25 $2.18 $2.19 256 254

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use LCTX stock historical prices to predict future price movements?
Trend Analysis: Examine the LCTX stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the LCTX stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics. Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa mul... LCTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT